• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人眼眶成纤维细胞原代培养中细胞异质性的证据。

Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.

作者信息

Smith T J, Sempowski G D, Wang H S, Del Vecchio P J, Lippe S D, Phipps R P

机构信息

Department of Medicine, Albany Medical College, New York 12208, USA.

出版信息

J Clin Endocrinol Metab. 1995 Sep;80(9):2620-5. doi: 10.1210/jcem.80.9.7673404.

DOI:10.1210/jcem.80.9.7673404
PMID:7673404
Abstract

Orbital fibroblasts in culture display phenotypic attributes that distinguish them from fibroblasts derived from other anatomical regions. The current studies were conducted to define potential cellular heterogeneity among orbital fibroblasts with regard to 1) differential expression of Thy-1, a 25-kilodalton glycoprotein associated with cell signaling; 2) cells undergoing a change in shape in response to prostaglandin E2 (PGE2); and 3) differences in morphology and Thy-1 expression between single cell-derived clonal fibroblast strains. On the basis of flow cytometric analysis using an anti-Thy-1 monoclonal antibody, 65% of intact orbital fibroblasts expressed surface Thy-1 (n = 5; range, 54-71%). In contrast, greater than 95% of the fibroblasts present in the five dermal strains tested were Thy-1 positive. A total of six strains of orbital fibroblasts were assessed for their shape change response to a 4-h treatment with PGE2 (100 nmol/L). A mean of 37% of the fibroblasts present in each culture responded to PGE2 (range, 22-50%). In contrast, only 1% of dermal fibroblasts exhibited any change in morphology. Three separate clones were generated from a single parent strain of Graves' orbital fibroblasts. These clones consisted of homogeneous appearing cells; however, substantial clone to clone differences in morphology were stably expressed for several population doublings. Thy-1 was expressed uniformly in cells of two clones, whereas the third was Thy-1 negative. Factor VIII and smooth muscle-specific alpha-actin were undetectable in any of the orbital or dermal cultures examined. Thus, Thy-1 expression is uniform in fibroblasts from certain anatomical regions such as the skin and heterogeneous in cells derived from human lung and orbit. These findings suggest that human orbital connective tissue may have a complexity not previously appreciated.

摘要

培养的眼眶成纤维细胞表现出一些表型特征,使其有别于源自其他解剖区域的成纤维细胞。目前的研究旨在确定眼眶成纤维细胞之间潜在的细胞异质性,具体涉及以下方面:1)Thy-1的差异表达,Thy-1是一种与细胞信号传导相关的25千道尔顿糖蛋白;2)细胞对前列腺素E2(PGE2)的形状变化反应;3)单细胞来源的克隆成纤维细胞株之间的形态学和Thy-1表达差异。基于使用抗Thy-1单克隆抗体的流式细胞术分析,65%的完整眼眶成纤维细胞表达表面Thy-1(n = 5;范围为54 - 71%)。相比之下,在所测试的五种皮肤细胞株中,超过95%的成纤维细胞Thy-1呈阳性。总共评估了六株眼眶成纤维细胞对100 nmol/L PGE2处理4小时后的形状变化反应。每种培养物中平均37%的成纤维细胞对PGE2有反应(范围为22 - 50%)。相比之下,只有1%的皮肤成纤维细胞表现出形态学上的任何变化。从Graves眼眶成纤维细胞的单个亲代细胞株中产生了三个独立的克隆。这些克隆由外观均匀的细胞组成;然而,在几个群体倍增过程中,克隆之间在形态学上存在显著且稳定表达的差异。Thy-1在两个克隆的细胞中均匀表达,而第三个克隆为Thy-1阴性。在所检查的任何眼眶或皮肤培养物中均未检测到因子VIII和平滑肌特异性α-肌动蛋白。因此,Thy-1在某些解剖区域如皮肤的成纤维细胞中表达一致,而在源自人肺和眼眶的细胞中表达不均一。这些发现表明人类眼眶结缔组织可能具有以前未被认识到的复杂性。

相似文献

1
Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.人眼眶成纤维细胞原代培养中细胞异质性的证据。
J Clin Endocrinol Metab. 1995 Sep;80(9):2620-5. doi: 10.1210/jcem.80.9.7673404.
2
Prostaglandin E2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate.
J Clin Endocrinol Metab. 1995 Dec;80(12):3553-60. doi: 10.1210/jcem.80.12.8530598.
3
Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.眼眶成纤维细胞的异质性可能决定甲状腺相关眼病的临床表现。
J Clin Endocrinol Metab. 2002 Jan;87(1):385-92. doi: 10.1210/jcem.87.1.8164.
4
Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts.评估人类眼眶成纤维细胞中与cAMP水平升高相关的快速形态变化。
Exp Cell Res. 1998 Dec 15;245(2):360-7. doi: 10.1006/excr.1998.4273.
5
Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.Graves眼病患者眼眶成纤维细胞中Thy-1(CD90)表达增强的证据。
Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255.
6
Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts.转化生长因子-β在培养的人眼眶成纤维细胞中诱导1型纤溶酶原激活物抑制剂的产生。
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1411-9.
7
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.人成纤维细胞亚群中的Thy-1表达定义了肌成纤维细胞或脂肪成纤维细胞表型。
Am J Pathol. 2003 Oct;163(4):1291-300. doi: 10.1016/S0002-9440(10)63488-8.
8
Human orbital fibroblasts in culture express ganglioside profiles distinct from those in dermal fibroblasts.
J Clin Endocrinol Metab. 1995 Sep;80(9):2668-74. doi: 10.1210/jcem.80.9.7673410.
9
Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes.人眼眶中的成纤维细胞亚群:Thy-1+和Thy-1-亚群表现出不同的表型。
Eur J Immunol. 2002 Feb;32(2):477-85. doi: 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U.
10
Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy.前列腺素E2可引起Graves眼病患者培养的眼眶成纤维细胞发生形态学改变。
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5094-8. doi: 10.1073/pnas.91.11.5094.

引用本文的文献

1
PAPP-A as a Potential Target in Thyroid Eye Disease.PAPP-A 作为甲状腺眼病的潜在靶点。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3119-3125. doi: 10.1210/clinem/dgae339.
2
Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy.成纤维细胞参与甲状腺相关性眼病提示新的治疗方法。
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S9-S18. doi: 10.1097/IOP.0000000000002509. Epub 2023 Dec 4.
3
The Role of Interleukin-17A and NLRP3 Inflammasome in the Pathogenesis of Graves' Ophthalmopathy.
白细胞介素-17A和NLRP3炎性小体在格雷夫斯眼病发病机制中的作用
Life (Basel). 2023 Apr 13;13(4):1007. doi: 10.3390/life13041007.
4
Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease.了解甲状腺眼病的发病机制与有效治疗相交叉。
J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S13-S26. doi: 10.1210/clinem/dgac328.
5
Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy.特普鲁单抗改变纤维细胞基因表达:甲状腺相关眼病的影响。
J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4037-e4047. doi: 10.1210/clinem/dgac415.
6
Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts RhoA-Mediated ERK and p38 Signaling Pathways.辛伐他汀和 ROCK 抑制剂 Y-27632 通过 RhoA 介导的 ERK 和 p38 信号通路抑制格雷夫斯眼病眼眶成纤维细胞的肌成纤维细胞分化。
Front Endocrinol (Lausanne). 2021 Feb 1;11:607968. doi: 10.3389/fendo.2020.607968. eCollection 2020.
7
Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.辛伐他汀通过调节 FoxO3a 信号通路抑制格雷夫斯眼病眼眶成纤维细胞中 CYR61 的表达。
Mediators Inflamm. 2021 Jan 20;2021:8888913. doi: 10.1155/2021/8888913. eCollection 2021.
8
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy.特罗特鲁单抗治疗甲状腺相关眼病的新疗法。
Front Endocrinol (Lausanne). 2020 Dec 17;11:610337. doi: 10.3389/fendo.2020.610337. eCollection 2020.
9
Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy.甲状腺相关眼病:特普西单抗作为一种有前途的医学治疗方法的出现。
Best Pract Res Clin Endocrinol Metab. 2020 Jan;34(1):101383. doi: 10.1016/j.beem.2020.101383. Epub 2020 Jan 31.
10
Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.CD34+ 纤维细胞伪装成眼眶成纤维细胞在甲状腺相关眼病中的潜在作用。
J Clin Endocrinol Metab. 2019 Feb 1;104(2):581-594. doi: 10.1210/jc.2018-01493.